PCYN (Procyon) Interest Expense : $0.00 Mil (TTM As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Procyon Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Procyon's interest expense for the three months ended in Jun. 2024 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2024 was $0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Procyon's Operating Income for the three months ended in Jun. 2024 was $ 0.01 Mil. Procyon's Interest Expense for the three months ended in Jun. 2024 was $ 0.00 Mil. GuruFocus does not calculate Procyon's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Procyon Interest Expense Historical Data

The historical data trend for Procyon's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Procyon Interest Expense Chart

Procyon Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Interest Expense

Get a 7-Day Free Trial

Procyon Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Interest Expense	Get a 7-Day Free Trial															-	-	-	-	-

Procyon Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Procyon (OTCPK:PCYN) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Procyon's Interest Expense for the three months ended in Jun. 2024 was $0.00 Mil. Its Operating Income for the three months ended in Jun. 2024 was $0.01 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2024 was $0.14 Mil.

Procyon's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

GuruFocus does not calculate Procyon's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Procyon Corp has enough cash to cover all of its debt. Its financial situation is stable.

Procyon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Procyon Corp (OTCPK:PCYN) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

164 Douglas Road, Oldsmar, FL, USA, 34677

Website

https://www.procyoncorp.com

Procyon Corp is a United-based company, through its subsidiary, it is engaged in developing and marketing proprietary medical products used to treat pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems. Its wound care products are sold through distributors to institutional customers such as hospitals, wound care clinics, skilled nursing facilities, home health agencies, and physicians and other healthcare practitioners. The firm's product lines are AMERX, AMERIGEL, and HELIX3 Bioactive Collagen. The skin and wound care products are marketed under the trademark AMERIGEL which contains the proprietary ingredient OAKIN which promotes wound healing and healthy skin. The corporation markets its products in the United States.

Executives

Foundation Speer	10 percent owner	2535 SUCCESS DRIVE, ODESSA FL 33556
Suggs Fred Wilson Jr	director	60 FOREST LANE, GREENVILLE SC 29605
Steven Mccomas	director	800 LASTAHOUSE DRIVE, VIDALIA GA 30474
Monica Mccullough	director	1095 55TH TERR SO, SAINT PETERSBURG FL 33705
Joseph Raymond Treshler	director	PO BOX 5719, CLEARWATER FL 33758
George Otis Borak	officer: Vice President	3300 COVE CAY DR, UNIT 7D, CLEARWATER FL 33760
Lynnda L Speer	10 percent owner	2535 SUCCESS DRIVE, ODESSA FL 33556
Richard M. Speer	10 percent owner	104 WOODMONT BOULEVARD, SUITE 415, NASHVILLE TN 37205
Speer Roy M Foundation	10 percent owner	2535 SUCCESS DRIVE, ODESSA FL 33556
Paul Edward Kudelko	director	28 WINSTON DR, BELLEAIR FL 33756
Justice Wolfe Anderson	director, officer: VP-Sales and Marketing	1300 S HIGHLAND AVE, CLEARWATER FL 33756
Regina Wolfe Anderson	director	1300 S HIGHLAND AVE, CLEARWATER FL 33756
Jeffrey S Slowgrove	director	C/O INFORMATION MANAGEMENT RESOURCES INC, 26750 US HIGHWAY N #500, CLEARWATER FL 34621
John C Anderson Trust	10 percent owner	440 S GULFVIEW BLVD, APT 1702N, CLEARWATER FL 33767
Michael Timothy Foley	director	2284 KINGS POINT DRIVE, LARGO FL 33774

Procyon Headlines

No Headlines